EORTC Metastatic Breast Cancer Module Development
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The overall aim of this project is to help improve the Health Related Quality of Life (HRQOL) of metastatic breast cancer (MBC) patients. There is currently an urgent and unmet need for specific tools to aid in the evaluation of HRQOL in MBC and this project aims to address these needs by developing a comprehensive EORTC questionnaire for assessing the HRQOL of this group. The new module will be used in conjunction with EORTC QLQ-C30 and will provide better measurement of the quality of life issues experienced by women with MBC. Interviews will be conducted with patients from several centres across Europe, guiding the development process in a patient centred way.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dorosłe kobiety w wieku 18 lat lub starsze
- •Diagnoza zaawansowanego raka piersi (rozprzestrzenionego na inne części ciała), również w przypadku choroby od początku zaawansowanej
- •Pacjentki leczone lub obecnie leczone z powodu zaawansowanego raka piersi (chemioterapia, hormony, leki celowane, radioterapia lub kombinacje)
- •Możliwość porozumienia się w języku ankiety
- •Zdolność do wyrażenia świadomej zgody na udział
✗ Disqualifies
- •Diagnoza wczesnego stadium raka piersi
- •Zaburzenia psychiatryczne lub problemy z pamięcią i myśleniem, które uniemożliwiałyby udział w rozmowach
- •Poprzedni udział w pierwszej fazie tego badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 8, 2026
- Sex
- Female only
Locations (22)
Ghent University Hospital
Ghent, Belgium
Centre hospitalier de l'Université de Montreal
Montreal, Canada
Odette Cancer Center - Sunnybrook Health Sciences Center
Toronto, Canada
Centre Hospitalier Lyon Sud
Lyon, France
University Hospital of Nimes
Nîmes, France
Centre Hospitalier Universitaire de Saint-Etienne
Saint-Etienne, France
Charité - Universitätsmedizin
Berlin, Germany
Helios University Hospital
Wuppertal, Germany
Tata Memorial Hospital
Mumbai, India
Istituto Nazionale Tumori
Naples, Italy
Veneto Institute of Oncology
Padova, Italy
Kansai Medical University Hospital
Osaka, Japan
National Cancer Centre Hospital
Tokyo, Japan
National Centre for Global Health and Medicine
Tokyo, Japan
King Hussein Cancer Center
Amman, Jordan
NKI-AVL Amsterdam
Amsterdam, Netherlands
Maria Sklodowska Curie National Research Institute of Oncology
Warsaw, Poland
Champalimaud Clinical Centre
Lisbon, Portugal
Comenius University and National Cancer Institute
Bratislava, Slovakia
Royal Navarre Hospital
Pamplona, Spain
St James University hospital
Leeds, United Kingdom
Mount Vernon Cancer Centre
Rickmansworth, United Kingdom
Trial contact
Eline Naert
Jean-Marc Bourque
Jennifer Leigh
Julien Péron
Irina Antochi
Frederci Fiteni
Astrid Basset
Pauline Corbaux
Wafa Esquis
Vesna Bjelic-radisic
Nora Nevries
Manjunath Nookala
Monica Pinto
Yuichiro Kikawa
Hiroto Ishiki
Ayumi Saito
Akihiko Shimomura
Omar Shamieh
Waleed Alrjoob
Kelly de Ligt
Lonneke van de Poll
Katarzyna Pogoda
Michal Chovanec
Peter Lesko
Juan Ignacio Arraras
Galina Velikova
Susan Hartup
Tara Chalk
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.